Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

A Novel Risk Engine for Diabetes-Related Complications Among Individuals with Type 1 Diabetes in the US

Speaker(s)

Tang T1, Fonseca V1, Shao H2, Shi L3
1Tulane University, New Orleans, LA, USA, 2University of Florida, Gainesville, FL, USA, 3Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA

Objective

This study aimed to develop a risk engine that consists of multiple risk equations for predicting micro- and macrovascular complications for individuals with type 1 diabetes (T1D).

Methods

We used data from two US nationally representative study cohorts: the Diabetic Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) study, to develop the risk engine. 1,441 participants were enrolled in DCCT study and 1,375 of them were followed by the EDIC study. The microvascular outcomes included retinopathy, neuropathy, and nephropathy. The macrovascular outcomes included myocardial infarction (MI), cerebrovascular events, death from cardiovascular diseases, silent MI, congestive heart failure (CHF). Cox proportional hazard models and logistic regression together with stepwise model selection method were used to select significant risk factors.

Results

The baseline HbA1c and duration of diabetes were the most common significant risk factors for microvascular outcomes (all p-values <0.05). Gender and drinking status were the other significant risk factors for retinopathy (both p-values <0.05). Albumin excretion rate (AER), age, body mass index (BMI), and high-density lipoprotein (HDL) were the other significant risk factors for nephropathy (all p-values< 0.05). Retinopathy at baseline and age were the other significant risk factors for neuropathy (both p-values < 0.05). For the macrovascular outcomes, significant risk factors included age, duration of diabetes, level of HbA1c, BMI, systolic blood pressure (SBP), high-density lipoprotein, low-density lipoprotein, and gender (each p-value < 0.05, all the data of potential risk factors used were collected at DCCT baseline) .

Conclusion

This risk engine for diabetes complications was developed for the US individuals with T1D. External validation process is needed for this new risk engine.

Code

RWD113

Topic

Clinical Outcomes, Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics, Clinical Outcomes Assessment

Disease

Cardiovascular Disorders, Neurological Disorders